Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.
about
Dexamethasone-(C21-phosphoramide)-[anti-EGFR]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency against pulmonary adenocarcinoma (A549)Gemcitabine-(5'-phosphoramidate)-[anti-IGF-1R]: molecular design, synthetic organic chemistry reactions, and antineoplastic cytotoxic potency in populations of pulmonary adenocarcinoma (A549)Simultaneous Dual Selective Targeted Delivery of Two Covalent Gemcitabine Immunochemotherapeutics and Complementary Anti-Neoplastic Potency of [Se]-MethylselenocysteineAnti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-EGFR] in Dual-combination with Epirubicin-(C3-amide)-[anti-HER2/neu] against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3) and the Complementary Effect of Mebendazole.Synthesis of Gemcitabine-(C4-amide)-[anti-HER2/neu] Utilizing a UV-Photoactivated Gemcitabine Intermediate: Cytotoxic Anti-Neoplastic Activity against Chemotherapeutic-Resistant Mammary Adenocarcinoma SKBr-3.Influence of Alternative Tubulin Inhibitors on the Potency of a Epirubicin-Immunochemotherapeutic Synthesized with an Ultra Violet Light-Activated Intermediate: Influence of incorporating an internal/integral disulfide bond structure and AlternativeFludarabine- (C2-methylhydroxyphosphoramide)- [anti-IGF-1R]: Synthesis and Selectively "Targeted"Anti-Neoplastic Cytotoxicity against Pulmonary Adenocarcinoma (A549)Gemcitabine-(C4-amide)-[anti-HER2/neu] Anti-Neoplastic Cytotoxicity in Dual Combination with Mebendazole against Chemotherapeutic-Resistant Mammary Adenocarcinoma.Anti-Neoplastic Cytotoxicity of Gemcitabine-(C4-amide)-[anti-HER2/neu] in Combination with Griseofulvin against Chemotherapeutic-Resistant Mammary Adenocarcinoma (SKBr-3).
P2860
Q28829762-9A184758-1E1C-41B8-AB4A-094435CE69D7Q33578254-A976DA22-E6BE-4272-9E87-27C64C6CC88BQ35222776-E70E8A67-89FF-4B7F-9ECE-4D71FCCED43DQ35237773-64A6F8A9-7EEF-471C-8F39-935C88ED1A3EQ35892041-B2204067-B7F5-4316-9B87-A23DAD1A0E04Q35892045-23FE1653-37C6-481F-A462-B4A31DB19CD7Q36311218-E6EC11A8-965A-40A6-A0CD-77E3973DD518Q40649082-FD6B6823-8999-4639-A103-A5640026E4FBQ40678981-9B67DC2F-27F2-4250-B02E-163C6A89FCEB
P2860
Epirubicin-[Anti-HER2/neu] Synthesized with an Epirubicin-(C13-imino)-EMCS Analog: Anti-Neoplastic Activity against Chemotherapeutic-Resistant SKBr-3 Mammary Carcinoma in Combination with Organic Selenium.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@ast
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@en
type
label
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@ast
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@en
prefLabel
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@ast
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@en
P2093
P2860
P356
P1476
Epirubicin-[Anti-HER2/neu] Syn ...... ination with Organic Selenium.
@en
P2093
Andrzej Sygula
Cody P Coyne
John Bailey
Lesya Pinchuk
Toni Jones
P2860
P356
10.4236/JCT.2011.21004
P577
2011-03-01T00:00:00Z